Clinical Trial Update: Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating loratadine/montelukast versus pseudoephedrine and placebo for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Loratadine (Loratadine)
• Montelukast (Montelukast)
• Pseudoephedrine (Pseudoephedrine)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED